PositiveID Corporation (fka PSID)

[Robsct]

By email alert from PSID...

PositiveID Corporation to Present at the Rodman & Renshaw Global Investment Conference

DELRAY BEACH, Fla., Sept. 2, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the Rodman & Renshaw 16th Annual Global Investment Conference taking place September 8-10, 2014, at the New York Palace Hotel in New York City. The Company's presentation is scheduled for 2:55 p.m. on September 9, 2014, and will also be available via webcast at: http://wsw.com/webcast/rrshq24/psid.

About PositiveID Corporation

PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.

Statements about PositiveID's future expectations constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on April 11, 2014, and 10-Qs filed on August 14, 2014, May 20, 2014, and November 19, 2013, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

CONTACT: PositiveID Corporation

Allison Tomek

561-805-8000

[e-mail]


Source: PositiveID Corporation


You are subscribed to PositiveID Investor Relations' e-mail alerts as [e-mail].

To update your e-mail and alert preferences, please click here.
To unsubscribe, please click here.

PositiveID
1690 South Congress , Delray Beach, FL 33445
Service provided by Shareholder.com